期刊文献+

微乳作为经皮给药载体的研究进展 被引量:17

下载PDF
导出
摘要 目的介绍微乳经皮给药研究进展。方法根据近年来文献,综述微乳作为经皮释药载体的吸收特性,及微乳处方组成对经皮释药性能的影响。结果微乳具有增加药物溶解度、提高药物穿透能力、降低药物刺激性和延缓药物释放等作用。结论微乳经皮给药具有广阔前景。
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第22期1681-1685,共5页 Chinese Pharmaceutical Journal
  • 相关文献

参考文献20

  • 1PELTOLA S,SAARINEN-SAVOLAINEN P,KIESVAARA J,et al.Microemulsion for topical delivery of estradiol[J].Int J Pharm,2003,254(2):99-107.
  • 2KREILGAARD M,PEDERSEN E J,JAROSZEWSKI J W.NMR characterisation and transdermal drug delivery potential of microemulsion systems[J].J Controlled Release,2000,69 (3):421-433.
  • 3WU H W,RAMACHANDRAN C,WEINER N D,etal.Topical transport of hydrophilic compounds using water-in-oil nanoemulsions[J].Int J Pharm,2001,220(1-2):63-75.
  • 4BONINA F P,MONTENEGRO L,SCROFANI N,et al.Effects of phospholipids based formulation on in vitro an in vivo percutaneous ansorption of methyl nicotinate[J].J Controlled Release,1995,34 (1):53-63.
  • 5CHEN H B,CHANGX L,WENGT,etal.A study of microemulsion systems for transdermal delivery of triptolide[J].J Controlled Release,2004,98(3):427-436.
  • 6PANLINO D,VENTURA C A,NISTICO S,et al.Lecithin microemulsions for the topical administration of ketoprofen:percutaneous adsorption through human skin and in vivo human skin tolerability[J].Int J Pharm,2002,244(1-2):21-31.
  • 7SINTOV A C,BOTNER S.Transdermal drug delivery using microemulsion and aqueous systems:Influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems[J].Int J Pharm,2006,311(1-2):55-62.
  • 8TROTTA M,MOREL S,GASCO M R.Effect of oil phase composition on the skin permert[J].Pharmazie,1997,52(1):50-53.
  • 9RHEE Y S,CHOI J G,PARK E S.Transdermal delivery of ketoprofen using microemulsions[J].Int J Pharm,2001,228(1-2):161-170.
  • 10PARK E S,CUI Y,YUN B J,et al.Transdermal delivery of piroxicam using microemulsions[J].Arch Pharm Res,2005,28(2):243-248.

二级参考文献21

  • 1Weber P,Lütschg J. Methylphenidate treatment[J].Pediapr Neurol,2002,26(4):261-266.
  • 2Panchagnula R.Transdermal delivery of drugs[J].Indian J Pharmacol,1997,29(2): 140-156.
  • 3Fang JY,Hwang TL,Fang CL, et al. In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug [J]. Int J Pharm, 2003,255(5) :153-166
  • 4Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery [J]. Eur J Pharm Sci, 2001,14(2): 101-114
  • 5Singh P,Boniello S,Liu P, et al. Transdermal iontophoretic delivery of methylphenidate HCl in vitro[J].Int J Pharm, 1999,178(3) 121-128.
  • 6Heylings JR, Diot S, Esdaile DJ, et al. A prevalidation study on the in vitro skin irritation function test (SIFT)for prediction of acute skin irritation in vivo: results and evaluation of ECVAM Phase Ⅲ [ J ]. Toxicol In Vitro,2003,17 (2): 123 - 38.
  • 7Faller C, Bracher M, Dami N, et al. Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics [ J ]. Toxicol In Vitro, 2002,16 (5) :557 - 572.
  • 8Mosmarn T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay [J]. J Immunol Meth, 1993,65( 1 -2) :55 -63.
  • 9Zhong GG, Han GC, Hee JS, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A [ J ]. Int J Pharm,1998,161 ( 1 - 2) :75 - 86.
  • 10Mohammed C, Manoj V. Aerosol-OT microemulsions as transdermal carriers of tatracaine hydrochloride [ J ].Drug Dev Ind Pharm, 2000,26(5):507 -512.

共引文献26

同被引文献199

引证文献17

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部